Clinical trial
to Assess the Efficacy and Safety of the Probiotic E. Coli Strain M17 on…
NCT00324532 · BioBalance Corporation, Industry · Completed
Key facts
| NCT number | NCT00324532 |
|---|---|
| Title | to Assess the Efficacy and Safety of the Probiotic E. Coli Strain M17 on Patients With GERD |
| Official title | An Open Label, Non Comparative, Prospective Pilot Study, to Assess the Efficacy and Safety of the Probiotic E. Coli Strain M17 on Patients With GERD |
| Lead sponsor | BioBalance Corporation, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | GERD |
| Intervention type | Drug |
| Interventions | ProBactrix |
| Enrollment | 60 |
| Start date | May 1, 2006 |
| Completion | May 1, 2007 |
| First posted | May 11, 2006 |
| Last update posted | Jan 27, 2015 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: